Literature DB >> 1385291

Appearance of hepatocytelike cells in the interlobular bile ducts of human liver in various liver disease states.

M Nomoto1, Y Uchikosi, N Kajikazawa, Y Tanaka, H Asakura.   

Abstract

Among 1,098 liver biopsy specimens obtained from patients with various liver diseases characterized by liver injury, 58 epithelial cells whose cytoplasms stained positively by the periodic acid-Schiff stain (digested with diastase) were recognized in the interlobular bile ducts of 37 specimens from 36 patients. Light microscopic study revealed that the cytoplasms of these cells were clear or stained weakly eosinophilic on hematoxylin and eosin staining and that the cell limits were distinct. From their reaction with periodic acid-Schiff stain and from electron microscopic observation it was clear that these cells contained an abundance of glycogen and were located among the normal bile duct cells surrounded by basement membrane. On electron microscopy, these cells had microvilli of equal sizes on their luminal surfaces and many irregularly sized microvilluslike cell membrane projections on their basal surfaces. They rested on basement membrane with basal spaces. These cells varied in size from 25.0 to 452.2 microns 2 (mean = 212.2 microns 2). In contrast, the sizes of normal bile duct cells and hepatocytes ranged from 20.0 to 69.3 microns 2 (mean = 34.2 microns 2) and from 113.0 to 860.3 microns 2 (mean = 447.0 microns 2), respectively. Immunohistochemical study with antiserum to cytokeratin 19, albumin and alpha 1-antitrypsin on serially cut frozen sections showed that some of these cells expressed markers of bile duct cells and hepatocytes. Some cells expressed only the markers of hepatocytes. Computer graphic three-dimensional reconstruction clearly demonstrated that these cells were located sparsely (but sometimes in groups) among normal interlobular bile duct cells, without any connection to the surrounding parenchymal hepatocytes.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1385291

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  8 in total

Review 1.  Role of stem cells in repair of liver injury: experimental and clinical benefit of transferred stem cells on liver failure.

Authors:  Mukaddes Esrefoglu
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

Review 2.  Wound healing in the liver with particular reference to stem cells.

Authors:  M Alison; M Golding; C Sarraf
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1998-06-29       Impact factor: 6.237

3.  Origin and structural evolution of the early proliferating oval cells in rat liver.

Authors:  S Paku; J Schnur; P Nagy; S S Thorgeirsson
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

4.  Preexisting epithelial diversity in normal human livers: a tissue-tethered cytometric analysis in portal/periportal epithelial cells.

Authors:  Kumiko Isse; Andrew Lesniak; Kedar Grama; John Maier; Susan Specht; Marcela Castillo-Rama; John Lunz; Badrinath Roysam; George Michalopoulos; Anthony J Demetris
Journal:  Hepatology       Date:  2013-03-19       Impact factor: 17.425

5.  Ductular hepatocytes. Evidence for a bile ductular cell origin in furan-treated rats.

Authors:  A E Sirica; T W Gainey; V R Mumaw
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

6.  Immunohistochemical detection of bcl-2 protein in normal and pathological human liver.

Authors:  F Charlotte; A L'Herminé; N Martin; Y Geleyn; M Nollet; P Gaulard; E S Zafrani
Journal:  Am J Pathol       Date:  1994-03       Impact factor: 4.307

7.  Morphometric and immunohistochemical characterization of human liver regeneration.

Authors:  E M Rubin; A A Martin; S N Thung; M A Gerber
Journal:  Am J Pathol       Date:  1995-08       Impact factor: 4.307

Review 8.  Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression.

Authors:  Alphonse E Sirica; Mario Strazzabosco; Massimiliano Cadamuro
Journal:  Adv Cancer Res       Date:  2020-12-09       Impact factor: 6.242

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.